German Biotech Stock News

Thyssenkrupp (XTRA:TKA) has just posted Q2 2026 numbers that show revenue of €7.2b and a basic EPS loss of €0.57, with net income excluding extra items at a loss of €353m. Over the prior five reported quarters, revenue has ranged from €7.2b to €8.8b while basic EPS has swung between a loss of €1.70 and a profit of €1.03. This highlights how sensitive earnings have been to shifts in margins and one off items. With analysts in the provided data pointing to strong earnings growth and a recent...

Dürr (XTRA:DUE) has just reported its Q1 2026 results, following recent quarters in which quarterly revenue ranged from about €1.0 billion to €1.1 billion and basic EPS moved between a loss of €1.62 and a profit of €0.36 per share. Over that period, the company recorded quarterly revenue between €1,000.9 million and €1,142.9 million, while basic EPS ranged from a Q2 2025 loss of €1.62 per share to Q3 and Q4 2025 profits of €0.36 and €0.27 respectively. This backdrop highlights mixed earnings,...

Eleving Group (DB:OT8) has just posted another quarter of detailed numbers, with Q4 2025 revenue at €48.3 million, basic EPS of €0.036 and trailing 12 month EPS of €0.197 giving investors a clear view of how recent trading has fed into full year profitability. Over the past year, revenue on a trailing 12 month basis moved from €159.7 million to €194.9 million, while EPS tracked in a tight range between €0.184 and €0.203. This sets the backdrop for current sentiment on the stock at around...

Villeroy & Boch (XTRA:VIB3) has come out of Q4 2025 with total revenue of €371.8 million and net income of €6.2 million, equal to basic EPS of €0.23. On a trailing twelve month basis, revenue sits at €1.45 billion with net income of €14.7 million and EPS of €0.55. Over the last year, revenue on a trailing basis has moved from €1.42 billion to €1.45 billion, alongside earnings growth of 149.2% and a net profit margin that has shifted from 0.4% to 1%. For investors, this mix of higher...

Deutsche Beteiligungs (XTRA:DBAN) has opened 2026 on a softer note, with Q1 revenue of €4.99 million and basic EPS of €1.17 loss, compared with Q1 2025 revenue of €24.34 million and EPS of €0.51. Over recent quarters the company has seen revenue move between €14.32 million and €24.46 million, while EPS has ranged from €1.93 loss in Q4 2024 to €0.91 in Q4 2025. This sets up a mixed backdrop for the latest quarter and keeps the focus squarely on margins and loss control. See our full analysis...

Münchener Rückversicherungs-Gesellschaft in München (XTRA:MUV2) has just posted its Q1 2026 results with quarterly revenue for the most recent reported period at €15.6b and basic EPS at €7.36, set against a trailing twelve month EPS of €47.15 on revenue of €62.3b. Over recent quarters, revenue has moved in a relatively tight band between €14.9b and €16.5b while quarterly EPS ranged from €6.85 to €15.95. This gives you a clear read on how earnings power has translated into a trailing net...

SAP has rolled out fully autonomous, AI-powered robots in a live SAP logistics warehouse, using its Embodied AI to handle real-world fulfillment tasks. At SAP Sapphire 2026, the company introduced its Autonomous Enterprise vision and the SAP Business AI Platform, along with a series of new alliances and product launches. These moves highlight SAP's push to embed agent-focused automation and advanced workflow orchestration across its enterprise software portfolio. XTRA:SAP is trading at...

Nemetschek (XTRA:NEM) is back in focus after reporting first quarter 2026 results, with sales of €313.09 million and revenue of €320.12 million, alongside net income of €60.37 million. See our latest analysis for Nemetschek. Despite the firm Q1 results and its appearance at the UBS Best of Europe Virtual 1-on-1 Conference on 12 May 2026, Nemetschek’s share price has been under pressure, with the 90 day share price return down 10.85% and the 1 year total shareholder return down 50.26%. This...

Siemens Healthineers (XTRA:SHL) is back in focus after agreeing a collaboration with HKSH Medical Group to make HKSH the first Photon Counting CT Simulator Reference Site in Asia. This highlights fresh attention on its radiotherapy technology footprint. See our latest analysis for Siemens Healthineers. The HKSH partnership comes after a busy spell that included half year results and a series of investor roadshows in London, Paris and the US. Yet the stock’s 1 month share price return is down...

KWS SAAT SE & Co. KGaA recently reported past third-quarter results showing sales of €937.3 million and net income of €283.8 million, alongside nine-month sales of €1,348.6 million and net income of €220 million to 31 March 2026. While sales edged higher year on year, earnings and basic EPS softened and cash flow felt pressure from higher receivables, even as leverage improved and full-year guidance was confirmed. We’ll now examine how resilient nine-month sales but weaker earnings and cash...

Zalando (XTRA:ZAL) recently reported first quarter 2026 results that showed sales of €2,996.1 million and a shift from a €9.9 million net profit a year earlier to an €87.6 million net loss. See our latest analysis for Zalando. The recent quarterly loss has coincided with weaker momentum in the stock, with the share price down 5.62% over one day and showing a 1 year total shareholder return decline of 40.76%. If Zalando's recent swing to a quarterly loss has you reassessing your portfolio,...

BASF (XTRA:BAS) has drawn fresh attention after first quarter 2026 earnings showed sales of €16,020 million, along with higher net income of €927 million and increased earnings per share compared with a year earlier. See our latest analysis for BASF. Despite a small 1-day share price decline of 0.56% to €53.16 and a 30-day share price return that is down 2.82%, BASF’s year to date share price return of 18.71% and 1-year total shareholder return of 22.41% point to momentum that has built over...

K+S (XTRA:SDF) has just posted its Q1 2026 numbers, with revenue of €1,060.8 million and a basic EPS loss of €0.88, while the trailing twelve months show revenue of €3.7 billion and a basic EPS loss of €7.36 as the company continues to work through a loss-making stretch. Over recent quarters, revenue has moved from €964.7 million in Q1 2025 to €1,060.8 million in Q1 2026, while quarterly EPS has swung between a profit of €0.48 and a loss of €9.68, keeping margins under pressure and putting...

Klaus-Michael Kühne, via Kühne Aviation GmbH, has raised his voting rights in Deutsche Lufthansa (XTRA:LHA) to 20%. This move represents a clear shift in the airline's shareholder structure toward a larger anchor investor position. The increase in influence could affect board representation and future decision making within the company. Deutsche Lufthansa operates as a major European airline group, with activities spanning passenger traffic, cargo, and related aviation services. The airline...

Aurubis (XTRA:NDA) just posted a busy Q2 2026, with revenue of €6.0b and net income of €479m translating into basic EPS of €18.34. The trailing twelve months show €20.4b of revenue, €921m of net income and EPS of €21.10, supported by 32.5% earnings growth and a net margin that improved to 4.5% from 3.8% over the past year. Over recent quarters, revenue has moved from €4.4b in Q4 2025 to €5.3b in Q1 2026 and now €6.0b in Q2 2026, with quarterly EPS rising alongside from €0.97 to €7.36 and then...

q.beyond (XTRA:QBY0) opened Q1 2026 with revenue of €42.816 million and a quarterly loss of €1.129 million, or EPS of €0.05, while trailing twelve month EPS stands at €0.034668 on net income of €0.845 million from revenue of €179.007 million. Over recent quarters, the company has seen revenue move from €51.184 million in Q4 2024 to €46.397 million in Q1 2025 and then to €42.816 million in Q1 2026, with quarterly EPS shifting from a loss of €0.064456 in Q4 2024 to a loss of €0.019866 in Q1...

HOCHTIEF (XTRA:HOT) opened 2026 with Q1 revenue of about €9.4b and basic EPS of €2.79, supported by net income of €210.0m. The company has seen quarterly revenue move from €8.9b and EPS of €4.09 in Q1 2025 to a trailing twelve month tally of about €38.6b and EPS of €10.69, giving investors a fuller read on the recent earnings trajectory. With a trailing net profit margin of 2.1% compared with a prior 2.7%, the latest results put the spotlight firmly on how sustainable HOCHTIEF's margins look...

GEA Group (XTRA:G1A) opened 2026 with Q1 revenue of €1.3b and basic EPS of €0.62, as the company reported net income from continuing operations of €100.1m. Over recent quarters, revenue has moved between €1.3b and €1.6b, while basic EPS has ranged from €0.56 to €0.75. This gives investors a clear view of how the top line and per share earnings have been tracking into this latest print. With net margins holding in the mid single digits, the focus now is on how consistently the company can...

Recent performance snapshot Mercedes-Benz Group (XTRA:MBG) has attracted fresh attention after a mixed stretch in the stock, with gains over the past week contrasting with weaker returns over the month and past 3 months. At a last close of €50.26, the company shows a 0.3% gain over 1 day and about 4.9% over 7 days, while being down roughly 6.7% over the past month and 13.9% over the past 3 months. See our latest analysis for Mercedes-Benz Group. Looking beyond the recent pullback,...

Recent performance snapshot Porsche Automobil Holding (XTRA:PAH3) has slipped about 21% year to date and around 9% over the past year, while the stock shows a roughly 29% total return decline across the past three years. See our latest analysis for Porsche Automobil Holding. Recent trading has been mixed, with a 7 day share price return of 4.33% offering a brief rebound, while the 90 day share price return is down 10.68% and the 3 year total shareholder return has declined 28.48%. This...

MTU Aero Engines (XTRA:MTX) is back in focus after its latest quarterly report, which showed €2,231 million in sales and €200 million in net income, along with updated earnings per share data. See our latest analysis for MTU Aero Engines. The recent earnings release, which combined higher sales with lower net income and earnings per share, came against a share price that is now €295.5 and has fallen 9.83% over 30 days and 20.39% year to date. The 5 year total shareholder return of 48.79%...

The European market has recently experienced a modest uptick, with the pan-European STOXX Europe 600 Index showing gains amid easing geopolitical tensions and strong corporate earnings. However, potential tariff threats from the U.S. have added pressure to the market landscape. In such an environment, dividend stocks can offer investors a measure of stability and income, as they typically represent companies with robust financial health and consistent cash flow generation.

Redcare Pharmacy (XTRA:RDC) drew investor attention after reporting first quarter 2026 results, with sales of €849.5 million versus €717.3 million a year earlier and a net loss of €10.5 million versus €10.8 million. See our latest analysis for Redcare Pharmacy. The latest first quarter results appear to have reset sentiment in the short term, with the share price up 6.93% over one day and 19.05% over 30 days. However, the year to date share price return of 28.48% and 1 year total shareholder...

What Befesa’s latest earnings tell you Befesa (XTRA:BFSA) reported first quarter 2026 earnings with sales of €285.21 million and net income of €20.7 million, compared with €308.38 million and €18.62 million a year earlier. Basic earnings per share from continuing operations came in at €0.52 for the quarter, versus €0.47 in the prior year period, highlighting a period in which profitability metrics and revenue moved in different directions. See our latest analysis for Befesa. The first quarter...